KRAS and carcinoma: In particular, the KRAS mutation is associated with histologic progression of adenomas toward a villous histology and higher grades of dysplasia, which suggests that this mutation occurs during the late stages of adenoma progression along with an advanced morphological phenotype and not as an intermediary step in development from adenoma to carcinoma [21, 31–33].